1. 1) 竹下幸男, 神田 隆: 血液脳関門・血液神経関門の視点からみた自己免疫性神経疾患の病態. Modern Physician 36 (7): 635-638, 2016.
2. 2) Polman CH, et al: A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354: 899-910, 2006. 10.1056/NEJMoa044397-DOI
3. 3) Biogen: Global natalizumab (Tysabri) postmarketing PML update. Updated March 2022.
4. 4) 三須建郎: 視神経脊髄炎関連疾患 (NMOSD). Brain Nerve 73 (5): 475-482, 2021.
5. 5) Misawa S, et al: Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial. Lancet Neurol 17 (6): 519-529, 2018.